For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Māori authority locked and loaded
Wednesday 22 June 2022, 09:00 AM

Interim Māori Health Authority / Te Mana Hauora Māori co-chair Sharon Shea [image: supplied]
Alan Perrott talks with a key figure in the health reforms, Sharon Shea, interim Māori Health Authority / Te Mana Hauora Māori co-chair
We are going to deliver short-term results because we are all about action and accountability and that’s all we can do
Stress and excitement leve
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.